Technologies
PDF


WARF: P130048US01

  • Assigned to WARF as biological material.

Phospho-Specific Antibody to Study Circadian Rhythm Gene PER2


INVENTORS -

Randal Tibbetts, Naval Shanware

The Wisconsin Alumni Research Foundation (WARF) is seeking commercial partners interested in developing antibodies that can detect phosphorylated forms of PER2 protein, which impacts sleep regulation and tumor suppression.
OVERVIEWCircadian rhythms refer to the 24-hour cycles of biological processes that promote daily functioning. The synchronization of an organism’s internal clock to external cues like light and darkness is called entrainment. In mammals, entrainment is critically influenced by the gene known as PERIOD2 (or PER2). Mutation of this gene can lead to lifelong sleep abnormalities. Specifically, mutations can result in differently phosphorylated proteins.

Previous studies have not been able to directly identify PER2 proteins phosphorylated at specific residue sites in vivo. To do so could help clarify the mechanisms and role of PER2 phosphorylation on healthy functioning.
THE INVENTIONUW–Madison researchers have developed phospho-PER2 antibodies that recognize PER2 protein phosphorylated by the enzyme casein kinase 1. The antibodies selectively recognize forms of the protein phosphorylated on Serine-662, -665 and -668.
APPLICATIONS
  • Reagent for studying PER2 regulation in response to circadian and noncircadian cues
KEY BENEFITS
  • Only phospho-PER2 antibody in existence
  • Selectively recognizes phosphorylated forms of PER2 in vivo
ADDITIONAL INFORMATION
For More Information About the Inventors
Publications
  • Shanware N.P., Hutchinson J.A., Kim S.H., Zhan L., Bowler M.J. and Tibbetts R.S. 2011. Casein Kinase 1-Dependent Phosphorylation of Familial Advanced Sleep Phase Syndrome-Associated Residues Controls PERIOD2 Stability. J. Biol. Chem. 14, 12766 - 12774.
Contact Information
For current licensing status, please contact Jennifer Gottwald at jennifer@warf.org or 608-960-9854.
The WARF Advantage

Since its founding in 1925 as the patenting and licensing organization for the University of Wisconsin-Madison, WARF has been working with business and industry to transform university research into products that benefit society. WARF intellectual property managers and licensing staff members are leaders in the field of university-based technology transfer. They are familiar with the intricacies of patenting, have worked with researchers in relevant disciplines, understand industries and markets, and have negotiated innovative licensing strategies to meet the individual needs of business clients.